EPM
VTAE

Equitec Proprietary Markets’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Equitec Proprietary Markets’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-46,000
Closed -$962K – 161
2016
Q3 		$962K Buy
+46,000
New +$530K 0.05% 47

Equitec Proprietary Markets's VTAE Position: Q4 2016 in Review

Equitec Proprietary Markets sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 46,000 shares — an estimated $962K sold.

Equitec Proprietary Markets first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $962K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • Equitec Proprietary Markets reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • Equitec Proprietary Markets sold 46,000 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $962K.
  • Equitec Proprietary Markets first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
  • Equitec Proprietary Markets's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $962K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Equitec Proprietary Markets's 13F filing for Q4 2016, filed 24 Jan 2017.